期刊文献+

气压法治疗小儿Kasabaeh—Merritt现象17例分析 被引量:6

Clinical analysis of 17 cases of pneumatic compression therapy in infants with Kasabach-Merritt phenomenon
原文传递
导出
摘要 目的总结气压法治疗小儿Kasabach—Merritt现象(KMP)的疗效和安全性。方法回顾性分析1997年10月至2008年5月接受气压法治疗的17例KMP患儿的临床资料。17例中男11例,女6例;年龄3d~3岁,中位年龄3.5个月;病变位于躯干8例,下肢5例,上肢4例;瘤体最大直径均〉8cm;血小板均〈100×10^9/L,血红蛋白均〈110g/L,血清纤维蛋白原均〈2.0g/L。气压法治疗应用自行设计的“气压式血管瘤治疗器”(专利号:ZL97232266.3)。瘤体局部取材活检或手术切除组织病理检查以明确KMP的病理性质。结果2例患儿分别接受4和6个月的气压法治疗后瘤体消失,血液指标恢复正常,随访11个月和5年无复发,疗效评定为治愈;11例接受4~6个月气压法治疗,随访6~24个月病情继续好转,未再治疗,疗效评定为显效;2例接受6个月气压法治疗后随访5个月和2年,病情无进展,疗效评定为好转;2例接受气压法治疗6个月无效,改行手术切除治疗。组织病理学检查证实17例KMP中卡波西形血管内皮瘤14例,丛状血管瘤3例。结论气压法对四肢、躯干部位的KMP疗效确切,无明显不良反应。 Objective To summarize the efficacy and safety of employing pneumatic compression therapy in infants with Kasabach-Merritt phenomenon (KMP). Methods Seventeen patients with KMP ( 11 males, 6 females) were treated with pneumatic compression therapy from October 1997 to May 2008. And their clinical characteristics, course of treatment and clinical and laboratory data were retrospectively analyzed. Among 17 patients, 8 cases were located in trunk, 5 in lower extremities and 4 in upper extremities. The diameters of lesions exceeded 8 cm in all patients. The platelet count was all 〈 100×10^9/L while hemoglobin 〈 110 g/L and fibrinogen 〈 2. 0 g/L. The self-designed device for pneumatic compression henmangioma therapy was employed ( Patent No: ZL97232266.3 ). Biopsy and exairesis were performed from the local lesions with KMP in order to determine the pathological features. Results Two patients were cured after pneumatic compression therapy for 4 and 6 months respectively, and their lesions disappeared, blood parameters became normal and remained relapse-free after a 5/11-year follow-up. Eleven patients were effective after pneumatic compression therapy for 4 - 6 months, and improvement was demonstrated after 6 - 24 months follow-up without any treatment. Two patients showed improvement after pneumatic compression therapy for 6 months after a follow-up for 5 months or 2 years without progression. After a 6-month pneumatic compression therapy, 2 ineffective patients underwent surgical resection. There were 14 cases of kaposiform hemangioendothelioma ( KHE ) and 3 cases of tufted hemangioma ( TA ). Conclusion Pneumatic compression therapy has definite curative effects for KMP lesions in extremities and trunk and its side effects are fewer.
出处 《中华医学杂志》 CAS CSCD 北大核心 2009年第26期1830-1833,共4页 National Medical Journal of China
关键词 血管内皮瘤 贫血 溶血性 血小板减少 气体压缩疗法 Hemangioendothelioma Anemia, hemolytic Thrombocytopenia Pneumatic compression therapy
  • 相关文献

参考文献12

  • 1Szlechetka DM.Kasabach-Merritt syndrome:a case review.Neonatal Netw,1998,17:7-15.
  • 2Enjolras O,Wassef M,Mazoyer E,et al.Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas.J Pediatr,1997,130:631-640.
  • 3Sarkar M,Mulliken JB,Kozakewich HPW,et at.Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon)is associated with Kaposiform hemangioendothelioma and not withcommon infantile hemangioma.Plast Reconstr Surg,1997,100:1377-1386.
  • 4Estedy NB.Kasahach-Merritt syndrome in infants.J Am AcedDermatol,1983,8:504-513.
  • 5Lyons LL,North PE,Mac-Moune Lai F,et al.Kaposiformhemangioendothelioma:a study of 33 eases emphasizing itspathologic,immunophenotypic,and biologic uniqueness from juvenile hemangioma.Am J Surg Pathol,2004,28:559-568.
  • 6Ezekowitz RA,Mulliken JB,Folkman J.Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.N Engl JMed,1992,326:1451-1463.
  • 7Haisley-Royster C,Enjolras O,Frieden IJ,et al.Kasabechmerritt phenomenon:a retrospective study of treatment with vincristine.J Pediatr Hematol Oncol,2002,24:459-462.
  • 8Walsh MA,Carcao M,Pope E,et al.Kapasiform hemangioendothelioma presenting antenatally with a pericaxdial effusion.J Pediatr Hematol Oncol,2008,30:761-763.
  • 9Yesudian PD,Parslew R,Klafowski J,et al.Tufted angioma-associated Kasahach-Merritt syndrome treated with embolization and vincristine.Plast Reconstr Stag,2008,121:692-693.
  • 10Janic D,Brasanac D,Krstovski N,et al.The use of recombinant activated factor Ⅶ during major surgery in a child with KasabachMerritt syndrome.Paediatr Anaesth,2009,19:177-179.

同被引文献28

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部